Healthcare Services

Global Mental Health Clinical Trials Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Mental Health Clinical Trials Market Across 2026–2030?

The mental health clinical trials market has experienced robust expansion over recent years. Its valuation is projected to increase from $3.23 billion in 2025 to $3.52 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.9%. Historically, this expansion has been driven by several factors, including the rising incidence of mental health disorders, the growth in pharmaceutical research and development pipelines, heightened public awareness concerning mental health conditions, an uptick in funding for clinical research, and a greater adoption of standardized diagnostic methods.

The mental health clinical trials market size is anticipated to undergo significant expansion over the coming years, with projections indicating a rise to $4.89 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%.

This projected growth throughout the forecast period is fueled by several factors, including the increasing acceptance of digital mental health interventions, greater investment in personalized psychiatry research, the broadening of global mental health trial networks, growing regulatory backing for novel trial designs, and the expanded utilization of data-driven outcome assessment methods.

Key emerging patterns during this period encompass the increasing uptake of decentralized clinical trial models, the escalating application of digital therapeutics in trials, the growing incorporation of AI-based patient recruitment tools, the broadening scope of remote patient monitoring in studies, and a heightened emphasis on generating real-world evidence.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27343&type=smp

What Primary Drivers Are Shaping The Development Of The Mental Health Clinical Trials Market?

The increasing occurrence of mental health disorders is projected to boost the expansion of the mental health clinical trials market in the coming years. Mental health disorders are defined as conditions that significantly impact an individual’s emotions, thought processes, behavior, and overall psychological functioning. These disorders are becoming more common due to heightened stress from contemporary lifestyles, including workplace demands, social isolation, and constant digital connectivity. Mental health clinical trials contribute to advancements in patient care by assessing the safety and effectiveness of new medications, therapeutic approaches, and behavioral interventions for mental health conditions. For instance, in May 2024, the American Psychiatric Association, a US-based non-profit organization, indicated that in 2024, around 43% of adults in the USA reported feeling more anxious, an increase from 37% in 2023 and 32% in 2022. Thus, the growing prevalence of mental health disorders is propelling the growth of the mental health clinical trials market.

What Segmentation Levels Are Considered In The Mental Health Clinical Trials Market?

The mental health clinical trials market covered in this report is segmented –

1) By Phase: Phase I, Phase II, Phase III, Phase IV

2) By Study Design: Interventional, Observational, Other Study Designs

3) By Disorder: Anxiety Disorders, Depression, Bipolar Affective Disorder, Dissociation And Dissociative Disorders, Schizophrenia, Other Disorders

4) By Sponsor: Pharmaceutical And Biopharmaceutical Companies, Government Agencies, Other Sponsors

Subsegments:

1) By Phase I: Single Ascending Dose, Multiple Ascending Dose, First In Human, Pharmacokinetics Studies

2) By Phase II: Dose Ranging Studies, Proof Of Concept Studies, Randomized Controlled Trials, Open Label Studies

3) By Phase III: Large Scale Randomized Trials, Multicenter Studies, Comparative Effectiveness Trials, Double Blind Studies

4) By Phase IV: Post Marketing Surveillance, Long Term Safety Studies, Real World Evidence Studies, Pharmacovigilance Studies

Which Trends Are Influencing The Mental Health Clinical Trials Market?

Leading firms within the mental-health clinical trials sector are increasingly concentrating on creating novel solutions, including software-enhanced drug therapies, aiming to boost treatment effectiveness, tailor patient care, and improve practical therapeutic results. These therapies combine conventional medications with scientifically validated therapeutic software, thereby contributing to better patient outcomes through individualized care, increased adherence, and immediate support for behavioral or symptom management. As an illustration, in October 2024, Click Therapeutics Inc., a digital therapeutics company based in the US, introduced Click SE. This new product aims to spearhead software-enhanced drug therapies by integrating prescription software with pharmacotherapy to provide additional clinical advantages and facilitate new endpoints in mental-health clinical development. Click SE represents a product line primarily focused on software, comprising regulated mobile and cloud applications developed on Click’s AI-powered DTx platform. Its operation involves providing structured therapeutic programs, real-time symptom tracking, and digital support tailored to specific medications, all engineered to work in conjunction with a co-prescribed drug. Its distinctive functionalities encompass adaptive algorithms that customize content based on patient reactions, integration mechanisms for pharmacologic dosing timetables, and integrated metrics for objective trial endpoints. Its applications cover enhancing antipsychotics for negative symptoms, serving as an adjunctive therapy in depression, and offering support in substance-use disorders.

Which Leading Firms Are Contributing To The Growth Of The Mental Health Clinical Trials Market?

Major companies operating in the mental health clinical trials market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., IQVIA Holdings Inc., Biogen Inc., ICON plc., Parexel International Corporation, CMIC Holdings Co. Ltd., Medpace Holdings Inc., PSI CRO AG., Supernus Pharmaceuticals Inc., Worldwide Clinical Trials, Inc., Ergomed, Celerion Inc., Biotrial S.A.S., Lindus Health Ltd., Novotech Health Holdings Pte Ltd., Precision for Medicine Inc.

Read the full mental health clinical trials market report here:

https://www.thebusinessresearchcompany.com/report/mental-health-clinical-trials-global-market-report

How Does The Mental Health Clinical Trials Market Perform Across Major Global Regions?

North America was the largest region in the mental health clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mental health clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Mental Health Clinical Trials Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27343&type=smp

Browse Through More Reports Similar to the Global Mental Health Clinical Trials Market 2026, By The Business Research Company

Elevator And Escalator Global Market Report

https://www.thebusinessresearchcompany.com/report/elevator-and-escalator-global-market-report

Smart Elevators Global Market Report

https://www.thebusinessresearchcompany.com/report/smart-elevators-global-market-report

Iot In Elevators Global Market Report

https://www.thebusinessresearchcompany.com/report/iot-in-elevators-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795